Britain's blue-chip FTSE 100 kicked off the week higher on Monday, boosted by heavyweight healthcare and defence stocks, on ...

The medical sector took a beating in 2024, leaving many battered and trading near 52-week lows heading into 2025. While the ...

UnitedHealth Group faces unconfirmed allegations of inflating risk ratings for reimbursements, causing market panic despite ...

Asian equities were largely lower despite a weaker US dollar overnight, as Japan outperformed and India underperformed.

Follow along for live updates on stocks, bonds and other markets, including the Dow Jones Industrial Average, S&P 500 and Nasdaq Composite.

On Friday, the Food and Drug Administration declared the semaglutide shortage over, sending Hims & Hers shares down 26%.

Hartford Dividend and Growth Fund (I shares) underperformed the S&P 500 Index for the quarter. Read more here.

This little-known healthcare S&P/ASX 200 Index (ASX: XJO) share is now one of the largest companies in the index.

Healthcare has lagged the S&P 500 over the past two years, with investors showing real interest in mega-cap tech and growth stocks based on the artificial intelligence (AI) boom. While a late-year ...

We recently compiled a list of the 12 Best Performing Small Cap Stocks So Far in 2025. In this article, we are going to take ...

We recently compiled a list of the 12 Best Performing Small Cap Stocks So Far in 2025. In this article, we are going to take ...

Citi Group upgrades Indian stocks, predicts Nifty 50 Index to reach 26,000 by 2025, while adjusting sectoral ratings globally ...